Drug Shortage Report for TRIESENCE

Last updated on 2019-03-13 History
Report ID 73545
Drug Identification Number 02368676
Brand name TRIESENCE
Common or Proper name TRIESENCE 1ML SUSP x 12
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Active Ingredient(s) TRIAMCINOLONE ACETONIDE
Strength(s) 40MG
Dosage form(s) SUSPENSION
Route of administration INTRAVITREAL
Packaging size 1 ML
ATC code S01BA
ATC description ANTIINFLAMMATORY AGENTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2019-01-25
Estimated end date 2019-03-15
Actual end date 2019-03-12
Shortage status Resolved
Updated date 2019-03-13
Company comments
Health Canada comments
Contact Address 385 BOUCHARD BLVD
DORVAL, QUEBEC
CANADA H9S 1A9
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2019-03-13 French Compare
v13 2019-03-13 English Compare
v12 2019-03-08 French Compare
v11 2019-03-08 English Compare
v10 2019-02-22 French Compare
v9 2019-02-22 English Compare
v8 2019-02-15 French Compare
v7 2019-02-15 English Compare
v6 2019-02-08 French Compare
v5 2019-02-08 English Compare
v4 2019-01-26 English Compare
v3 2019-01-25 French Compare
v2 2019-01-25 English Compare
v1 2019-01-25 English Compare